Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferula communis extract is a plant-derived extract obtained from the roots, leaves, or rhizomes of *Ferula communis* L. (giant fennel), a herbaceous plant native to the Mediterranean region, North Africa, and Central Asia. The extract is typically prepared from a non-toxic chemotype of the plant or processed to remove ferulenol, a toxic prenylated coumarin with anticoagulant properties. Its primary active constituent is ferutinin, a sesquiterpenic alcohol ester that acts as an agonist at estrogen receptors, imparting phytoestrogenic, antioxidant, anti-inflammatory, and antiproliferative properties. Ferula communis extract is primarily investigated as a nutraceutical or botanical research compound for the relief of postmenopausal discomfort and sexual dysfunction, and has also been studied preclinically as an adjunct to tamoxifen chemotherapy in hormone receptor-positive breast cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferula communis extract.